Insider trades by month
US insider trades, March 2023
The 13,084 open-market buys and sales by US company CEOs, executives and directors filed in March 2023.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Akamai TechnologiesAKAM | Open-market buyAmendment | 23/03/07–23/03/31 | 23/03/31 | 1,643 sh5 trades | $76.20avg. | $125,197.63 | +2.2% | |
Axon EnterpriseAXON | Open-market sale10b5-1 plan | 23/03/29–23/03/31 | 23/03/31 | 222,606 sh16 trades | $220.39avg. | $49,059,057.81 | −6.9% | |
Matthew J. CoxChairman & CEO | MatsonMATX | Open-market sale | 23/03/31 | 23/03/31 | 8,819 sh | $60.01 | $529,228.19 | −3.1% |
| Open-market buy | 23/03/31 | 23/03/31 | 1,009,021 sh6 trades | $3.88avg. | $3,915,001.48 | No record | ||
Treace Medical ConceptsTMCI | Open-market sale | 23/03/30–23/03/31 | 23/03/31 | 133,498 sh2 trades | $25.54avg. | $3,410,148 | −12.6% | |
Five9FIVN | Open-market sale10b5-1 plan | 23/03/29–23/03/31 | 23/03/31 | 5,000 sh2 trades | $67.57avg. | $337,850 | −4.5% | |
John Earl JacksonDirector | Main Street CapitalMAIN | Open-market buy | 23/03/31 | 23/03/31 | 3,000 sh | $39.20 | $117,600 | +5.2% |
American Strategic InvestmentNYC | Open-market buy | 23/03/30–23/03/31 | 23/03/31 | 1,108 sh2 trades | $8.44avg. | $9,347.44 | +0.2% | |
| Open-market buy | 23/03/31 | 23/03/31 | 25,773 sh | $3.88 | $99,999.24 | +10.9% | ||
Main Street CapitalMAIN | Open-market sale | 23/03/29–23/03/31 | 23/03/31 | 14,919 sh3 trades | $39.44avg. | $588,460.55 | −8.9% | |
10% Owner | Open-market buy | 23/03/31 | 23/03/31 | 1,009,021 sh6 trades | $3.88avg. | $3,915,001.48 | No record | |
| Open-market buy | 23/03/31 | 23/03/31 | 1,009,021 sh6 trades | $3.88avg. | $3,915,001.48 | No record | ||
Jeffrey S. MeffordPresident | Midland States BancorpMSBI | Open-market sale | 23/03/31 | 23/03/31 | 1,600 sh | $21.33 | $34,128 | −5.2% |
John Taylor Maloney FitzgeraldPresident and CEO | KingswayKWY | Open-market buy | 23/03/31 | 23/03/31 | 230 sh | $9.05 | $2,081.5 | +0.0% |
Welsh, Carson, Anderson & Stowe XII10% Owner | Clearwater Analytics Holdings | Open-market sale | 23/03/31 | 23/03/31 | 729,953 sh | $14.50 | $10,584,318.5 | −100.0% |
Clearwater Analytics Holdings | Open-market sale | 23/03/31 | 23/03/31 | 729,953 sh | $14.50 | $10,584,318.5 | −100.0% | |
Clearwater Analytics Holdings | Open-market sale | 23/03/31 | 23/03/31 | 729,953 sh | $14.50 | $10,584,318.5 | −100.0% | |
John Bradley SorensonEVP, Global Operations | Boston ScientificBSX | Open-market sale | 23/03/31 | 23/03/31 | 4,000 sh | $50.00 | $200,000 | −10.4% |
Clearwater Analytics Holdings | Open-market sale | 23/03/31 | 23/03/31 | 729,953 sh | $14.50 | $10,584,318.5 | −100.0% | |
Kent A. HansenCFO & EVP | KingswayKWY | Open-market buy | 23/03/31 | 23/03/31 | 165 sh | $9.05 | $1,493.25 | +0.2% |
Other months
- September 20261,445
- June 202620,298
- May 202614,504
- April 20269,432
- March 202614,721
- February 202610,638
- January 20267,844
- December 202512,093
- November 202511,751
- October 202513,072
- September 202513,090
- August 202514,381
- July 20258,748
- June 202511,426
- May 202511,415
- April 20256,792
- March 202512,399
- February 202510,686
- January 20258,151
- December 202416,069
- November 202416,983
- October 20248,518
- September 202410,511
- August 202414,013
- July 202410,847
- June 202412,704
- May 202412,649
- April 20248,608
- March 202417,622
- February 202413,916
- January 20249,748
- December 202314,239
- November 202312,685
- October 20236,365
- September 20239,845
- August 202312,892
- July 20237,232
- June 202311,204
- May 202313,009
- April 20235,870
- March 202313,084
- February 202311,300
- January 20238,626